Alpha Teknova (NASDAQ:TKNO) Releases Quarterly Earnings Results

Alpha Teknova (NASDAQ:TKNO) announced its quarterly earnings results on Tuesday. The company reported ($0.11) EPS for the quarter, Zacks reports. Alpha Teknova had a negative return on equity of 35.30% and a negative net margin of 87.17%. The company had revenue of $9.27 million for the quarter, compared to analyst estimates of $9.10 million. Alpha Teknova updated its FY 2025 guidance to EPS.

Alpha Teknova Trading Down 1.2 %

Shares of TKNO stock opened at $5.97 on Thursday. The company has a market capitalization of $318.25 million, a P/E ratio of -8.07 and a beta of 0.34. The company has a current ratio of 4.73, a quick ratio of 3.94 and a debt-to-equity ratio of 0.12. The business’s 50 day moving average is $8.22 and its two-hundred day moving average is $6.88. Alpha Teknova has a twelve month low of $1.16 and a twelve month high of $10.37.

Wall Street Analyst Weigh In

Separately, Craig Hallum assumed coverage on Alpha Teknova in a report on Monday, February 10th. They issued a “buy” rating and a $12.00 price objective for the company.

About Alpha Teknova

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.